all ( 13 results found)
IMBRUVICA® (ibrutinib): New risk minimisation measures, including dose modification recommendations, due to the increased risk for serious cardiac events
Zolgensma (onasemnogene abeparvovec): Important Safety Information
Fluoroquinolones DHPC_HPRA_FINAL vs2 30-05-23
Gavreto DHPC dated 16 Jun 2023
Dzuveo DHCP letter
Dzuveo cover letter
EpiPen® Healthcare Professional Letter
EpiPen® Healthcare Professional Letter
EpiPen® Healthcare Professional Letter
EpiPen® Healthcare Professional Letter
EpiPen® Healthcare Professional Letter
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy
Topiramate: New restrictions to prevent exposure during pregnancy